2023-06-012024-05-312024-05-31false13412539DR P COSTANZO CARDIOLOGY LIMITED2025-02-2586220falseiso4217:GBPxbrli:pure134125392023-06-01134125392024-05-31134125392023-06-012024-05-31134125392022-06-01134125392023-05-31134125392022-06-012023-05-3113412539bus:SmallEntities2023-06-012024-05-3113412539bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3113412539bus:FullAccounts2023-06-012024-05-3113412539bus:PrivateLimitedCompanyLtd2023-06-012024-05-3113412539core:WithinOneYear2024-05-3113412539core:AfterOneYear2024-05-3113412539core:WithinOneYear2023-05-3113412539core:AfterOneYear2023-05-3113412539core:ShareCapital2024-05-3113412539core:SharePremium2024-05-3113412539core:RevaluationReserve2024-05-3113412539core:OtherReservesSubtotal2024-05-3113412539core:RetainedEarningsAccumulatedLosses2024-05-3113412539core:ShareCapital2023-05-3113412539core:SharePremium2023-05-3113412539core:RevaluationReserve2023-05-3113412539core:OtherReservesSubtotal2023-05-3113412539core:RetainedEarningsAccumulatedLosses2023-05-3113412539core:LandBuildings2024-05-3113412539core:PlantMachinery2024-05-3113412539core:Vehicles2024-05-3113412539core:FurnitureFittings2024-05-3113412539core:OfficeEquipment2024-05-3113412539core:NetGoodwill2024-05-3113412539core:IntangibleAssetsOtherThanGoodwill2024-05-3113412539core:ListedExchangeTraded2024-05-3113412539core:UnlistedNon-exchangeTraded2024-05-3113412539core:LandBuildings2023-05-3113412539core:PlantMachinery2023-05-3113412539core:Vehicles2023-05-3113412539core:FurnitureFittings2023-05-3113412539core:OfficeEquipment2023-05-3113412539core:NetGoodwill2023-05-3113412539core:IntangibleAssetsOtherThanGoodwill2023-05-3113412539core:ListedExchangeTraded2023-05-3113412539core:UnlistedNon-exchangeTraded2023-05-3113412539core:LandBuildings2023-06-012024-05-3113412539core:PlantMachinery2023-06-012024-05-3113412539core:Vehicles2023-06-012024-05-3113412539core:FurnitureFittings2023-06-012024-05-3113412539core:OfficeEquipment2023-06-012024-05-3113412539core:NetGoodwill2023-06-012024-05-3113412539core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3113412539core:ListedExchangeTraded2023-06-012024-05-3113412539core:UnlistedNon-exchangeTraded2023-06-012024-05-3113412539core:MoreThanFiveYears2023-06-012024-05-3113412539core:Non-currentFinancialInstruments2024-05-3113412539core:Non-currentFinancialInstruments2023-05-3113412539dpl:CostSales2023-06-012024-05-3113412539dpl:DistributionCosts2023-06-012024-05-3113412539core:LandBuildings2023-06-012024-05-3113412539core:PlantMachinery2023-06-012024-05-3113412539core:Vehicles2023-06-012024-05-3113412539core:FurnitureFittings2023-06-012024-05-3113412539core:OfficeEquipment2023-06-012024-05-3113412539dpl:AdministrativeExpenses2023-06-012024-05-3113412539core:NetGoodwill2023-06-012024-05-3113412539core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3113412539dpl:GroupUndertakings2023-06-012024-05-3113412539dpl:ParticipatingInterests2023-06-012024-05-3113412539dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3113412539core:ListedExchangeTraded2023-06-012024-05-3113412539dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3113412539core:UnlistedNon-exchangeTraded2023-06-012024-05-3113412539dpl:CostSales2022-06-012023-05-3113412539dpl:DistributionCosts2022-06-012023-05-3113412539core:LandBuildings2022-06-012023-05-3113412539core:PlantMachinery2022-06-012023-05-3113412539core:Vehicles2022-06-012023-05-3113412539core:FurnitureFittings2022-06-012023-05-3113412539core:OfficeEquipment2022-06-012023-05-3113412539dpl:AdministrativeExpenses2022-06-012023-05-3113412539core:NetGoodwill2022-06-012023-05-3113412539core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3113412539dpl:GroupUndertakings2022-06-012023-05-3113412539dpl:ParticipatingInterests2022-06-012023-05-3113412539dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3113412539core:ListedExchangeTraded2022-06-012023-05-3113412539dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3113412539core:UnlistedNon-exchangeTraded2022-06-012023-05-3113412539core:NetGoodwill2024-05-3113412539core:IntangibleAssetsOtherThanGoodwill2024-05-3113412539core:LandBuildings2024-05-3113412539core:PlantMachinery2024-05-3113412539core:Vehicles2024-05-3113412539core:FurnitureFittings2024-05-3113412539core:OfficeEquipment2024-05-3113412539core:AfterOneYear2024-05-3113412539core:WithinOneYear2024-05-3113412539core:ListedExchangeTraded2024-05-3113412539core:UnlistedNon-exchangeTraded2024-05-3113412539core:ShareCapital2024-05-3113412539core:SharePremium2024-05-3113412539core:RevaluationReserve2024-05-3113412539core:OtherReservesSubtotal2024-05-3113412539core:RetainedEarningsAccumulatedLosses2024-05-3113412539core:NetGoodwill2023-05-3113412539core:IntangibleAssetsOtherThanGoodwill2023-05-3113412539core:LandBuildings2023-05-3113412539core:PlantMachinery2023-05-3113412539core:Vehicles2023-05-3113412539core:FurnitureFittings2023-05-3113412539core:OfficeEquipment2023-05-3113412539core:AfterOneYear2023-05-3113412539core:WithinOneYear2023-05-3113412539core:ListedExchangeTraded2023-05-3113412539core:UnlistedNon-exchangeTraded2023-05-3113412539core:ShareCapital2023-05-3113412539core:SharePremium2023-05-3113412539core:RevaluationReserve2023-05-3113412539core:OtherReservesSubtotal2023-05-3113412539core:RetainedEarningsAccumulatedLosses2023-05-3113412539core:NetGoodwill2022-06-0113412539core:IntangibleAssetsOtherThanGoodwill2022-06-0113412539core:LandBuildings2022-06-0113412539core:PlantMachinery2022-06-0113412539core:Vehicles2022-06-0113412539core:FurnitureFittings2022-06-0113412539core:OfficeEquipment2022-06-0113412539core:AfterOneYear2022-06-0113412539core:WithinOneYear2022-06-0113412539core:ListedExchangeTraded2022-06-0113412539core:UnlistedNon-exchangeTraded2022-06-0113412539core:ShareCapital2022-06-0113412539core:SharePremium2022-06-0113412539core:RevaluationReserve2022-06-0113412539core:OtherReservesSubtotal2022-06-0113412539core:RetainedEarningsAccumulatedLosses2022-06-0113412539core:AfterOneYear2023-06-012024-05-3113412539core:WithinOneYear2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:CostValuation2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3113412539core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3113412539core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3113412539core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3113412539core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3113412539core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3113412539bus:Director12023-06-012024-05-31

DR P COSTANZO CARDIOLOGY LIMITED

Registered Number
13412539
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2024

DR P COSTANZO CARDIOLOGY LIMITED
Company Information
for the year from 1 June 2023 to 31 May 2024

Director

COSTANZO, Pierluigi, Dr

Registered Address

Ground Floor Cardigan House Swansea Enterprise Park
Castle Court
Swansea
SA7 9LA

Registered Number

13412539 (England and Wales)
DR P COSTANZO CARDIOLOGY LIMITED
Statement of Financial Position
31 May 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors-1,031
Cash at bank and on hand47,54026,565
47,54027,596
Creditors amounts falling due within one year3(13,263)(11,133)
Net current assets (liabilities)34,27716,463
Total assets less current liabilities34,27716,463
Net assets34,27716,463
Capital and reserves
Called up share capital1010
Profit and loss account34,26716,453
Shareholders' funds34,27716,463
The financial statements were approved and authorised for issue by the Director on 25 February 2025, and are signed on its behalf by:
COSTANZO, Pierluigi, Dr
Director
Registered Company No. 13412539
DR P COSTANZO CARDIOLOGY LIMITED
Notes to the Financial Statements
for the year ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20242023
Average number of employees during the year00
3.Creditors: amounts due within one year

2024

2023

££
Taxation and social security4,1782,446
Other creditors8,2217,490
Accrued liabilities and deferred income8641,197
Total13,26311,133